RLYB - Total Utang marang Modal Rallybio

Logo perusahaan publik Rallybio Corp (RLYB)

Rallybio Corporation (RLYB) bases its competitive advantage on patent law and the exclusivity of orphan drugs. This price chart on the GURU.Markets platform shows that the individual debt-to-equity ratio is 0.00. Rallybio Corporation (RLYB) develops innovative antibodies through partnerships with global laboratories to treat blood incompatibility. Business growth is driven by the success of the FNAIT program, a significant liquidity reserve, and a focus on high-cost drugs for rare pathologies.

RLYB: Total Utang marang Modal Rallybio Corp. 04.07.2022 - 31.10.2026

Rincian analitis perusahaan Rallybio Corporation

- rega lan prakiraan konsensus rega:
Bagan rega Rallybio Corp|RLYB - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Rallybio|RLYB - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Rallybio|RLYB - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku rallybio.com|RLYB - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Rallybio Corporation|RLYB - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Rallybio Corp|RLYB - Gunggung utang perusahaan|Utang marang nilai buku Rallybio|RLYB - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Rallybio|Indikator likuiditas cepet rallybio.com
- informasi bathi lan kelipatan valuasi:
RLYB - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:Rallybio Corporation
Barang utama Rallybio

Identifying fundamentally resilient assets requires analyzing the balance sheet structure via the total liabilities-to-equity ratio, which determines the business's degree of dependence on borrowed funds. Low financial leverage, as reflected in the total debt-to-equity ratio, confirms the ability of Rallybio Corporation (RLYB) to finance robotic automation for rare disease research without a critical debt burden, thereby reducing default risks amid fluctuating interest rates.

Analisis pesaing Rallybio Corporation

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal Eupraxia Pharma EPRX|Utang marang Ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Oramed Pharmaceuticals Inc. ORMP|Rasio Kabeh Utang marang Dana Pribadi ENTX|MindWalk - Total Utang marang Modal|ABVC - Total Utang marang Modal|Cumberland Pharmaceuticals (CPIX) - Utang marang Ekuitas|QNTM (quantumbiopharma.com) - Utang marang Ekuitas|Utang marang Ekuitas FibroGen|Utang marang Ekuitas TELO|Rasio Total Utang marang Ekuitas RANI (Rani Therapeutics)|SNYR - Utang marang Modal|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|pulmatrix.com - Utang marang Ekuitas|Pheton - Total Utang marang Modal|Koefisien Total Utang marang Modal Aptorum Group Limited APM|Lyra Therapeutics, Inc (LYRA) - Utang marang Ekuitas|Utang marang Modal Impact BioMedical, Inc. (IBO)|Rasio Total Utang marang Ekuitas TNFA|YCBD: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PRFX|Rasio Total Utang marang Ekuitas altamiratherapeutics.com CYTO|Utang marang Ekuitas Lipella LIPO|OptiNose Corp (OPTN) - Utang marang Modal|PIRS - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PROC (procapsgroup.com)|Petros Pharmaceuticals, Inc. (PTPI) - Utang marang Ekuitas|Utang Agregat marang Ekuitas QLI (Qilian International Holding Group)|Utang marang Ekuitas ACELYRIN, Inc.|Utang marang Modal TFF Pharmaceuticals, Inc TFFP